Full-Time

Media Relations and Content Manager

Posted on 8/18/2025

BioPhorum

BioPhorum

51-200 employees

Membership-based forums for biopharma and devices

No salary listed

London, UK

In Person

Category
Content & Writing (2)
,
Required Skills
Communications
Social Media
Journalism
Data Analysis
Requirements
  • Proven experience in media relations, journalism, or communications, ideally within Life Sciences.
  • Strong existing relationships with relevant journalists and media outlets.
  • Exceptional writing, editing, and storytelling skills, with the ability to translate complex scientific issues into clear, compelling content.
  • Experience managing social media channels and creating multimedia content, including webinars.
  • Knowledge of media monitoring tools and analytics platforms.
  • Strong organisational skills, with the ability to manage multiple projects and deadlines in a fast-paced environment.
  • Commercial mindset, with the ability to thrive in a face-based, growing business.
  • Excellent interpersonal skills, with the ability to build relationships and collaborate effectively with internal and external stakeholders.
  • A proactive, solutions-oriented approach, with the ability to think strategically and act tactically.
  • Experience working with senior leaders and acting as a trusted advisor.
Responsibilities
  • Build and maintain strong relationships with journalists, editors, and key media outlets across relevant industry print, broadcast, and digital platforms.
  • Manage BioPhorum’s PR agency and ensure maximum impact of all relevant activity.
  • Proactively pitch stories, press releases, and expert commentary to secure positive media coverage.
  • Monitor media coverage and public sentiment, providing regular reports and insights to BioPhorum’s Senior Leadership Team.
  • Prepare BioPhorum spokespeople for media interviews and public appearances and conferences etc, including preparing briefing materials, presentation decks and guiding on key messages.
  • Develop and execute a content strategy aligned with BioPhorum’s values, mission and goals.
  • Write, edit, and distribute high-quality content, including white papers, press releases, op-eds, blog posts, and social media updates.
  • Collaborate with internal teams to ensure content is accurate, consistent, and aligned with organisational strategies.
  • Manage the firm’s social media channels, creating engaging content and monitoring interactions to build a strong online presence and drive enquiries to BioPhorum’s product portfolio.
  • Oversee the production of multimedia content, such as webinars, videos, infographics, and podcasts, to support communications efforts and extend our brand reach.
  • Create campaign materials, such as email newsletters, webinar invites and landing pages to drive inbound traffic and ensure high engagement with our material and messaging.
  • Support the organisation of events, such as press conferences, roundtables and town halls, to amplify BioPhorum’s message and Thought Leadership positioning.
  • Collaborate with senior leadership and relevant teams across BioPhorum to ensure alignment across and engagement with all communications activities.
  • Develop and issue speaker and briefing notes for conferences and events where BioPhorum is in attendance, to ensure consistent and on-brand messaging.
  • Provide regular updates and reports on media coverage, campaign performance, and content metrics.

BioPhorum is a B2B membership organization that enables collaboration across global biopharmaceutical and medical device industries. It provides a non-competitive space where leaders and experts tackle shared challenges, define best practices, and advance projects through focused forums called Phorums. Members from license holders, manufacturers, CDMOs, and suppliers work on industry-wide initiatives to improve operations, reduce costs, and streamline regulatory processes, plus tools like the Digital Plant Maturity Model (DPMM) to guide digital transformation. Its goal is to accelerate progress in biopharma and medical device manufacturing by sharing knowledge, setting industry-wide practices, and improving efficiency and regulatory readiness.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

London, United Kingdom

Founded

2008

Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic Advisory Board with Pfizer, GSK, Eli Lilly executives accelerates adoption of BioPhorum standards.
  • Acquisitions of PharmaX, Inspired Pharma, Brookwood Global expand training and digital services by May 2026.
  • Rx-360 joint audits with BSI standardize SUS supplier quality, enabling scalable licensing revenue.

What critics are saying

  • EMA Joint Audit Programme commoditizes BioPhorum audits, eroding demand within 12-18 months.
  • Rapid 2025-2026 acquisitions dilute core membership focus, causing integration failures in 6-12 months.
  • Members defect as BioPhorum sells consulting via acquired firms, perceiving bias within 12-24 months.

What makes BioPhorum unique

  • BioPhorum operates 11 Phorums directing over 100 workstreams with 7500 experts since 2008.
  • BioPhorum facilitates pre-competitive collaboration among biopharma leaders and suppliers in safe spaces.
  • BioPhorum influences regulatory environments through outputs like USP <665> roadmaps and HCP databases.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Company News

PR Newswire
Feb 5th, 2026
BioPhorum forms Strategic Advisory Board with 14 pharma executives to accelerate industry collaboration

BioPhorum, a pharmaceutical industry collaborative network, has announced the formation of its inaugural Strategic Advisory Board comprising 14 senior executives from major pharmaceutical companies. The board will provide executive guidance on critical industry challenges including global regulation, new technology and supply chain resilience. Members include executives from Pfizer, GSK, Eli Lilly, Amgen, Sanofi, Merck, SK Pharmteco, Fujifilm BioTechnologies, eXmoor, Sartorius, UCB and Cytiva. The board will serve as a forum for strategic dialogue on pressing industry-wide challenges and opportunities. BioPhorum CEO Deborah Kobewka described the board's launch as "a defining milestone", noting that executive-led direction is crucial as the industry navigates volatility and a challenging global investment landscape. The board aims to help members turn market complexity into a shared roadmap for sustainable growth.

PharmiWeb.com
Dec 18th, 2025
BioPhorum acquires Inspired Pharma to enhance its training and support for pharmaceutical professionals worldwide

Media Release 17 December 2025 BioPhorum acquires Inspired Pharma to enhance its training and support for pharmaceutical professionals worldwide Strategic acquisition strengthens BioPhorum’s ability to deliver insight, expertise, and practical solutions to its global membership and life sciences client community across the pharmaceutical value chain BioPhorum is pleased to announce the acquisition of Inspired Pharma, a leading provider of specialist training for the...

PharmiWeb.com
May 20th, 2025
Biophorum Announces Appointment Of Dr. Uwe Buecheler To Board Of Directors

19 May 2025London, UKBioPhorum, the global organisation accelerating collaboration between biopharmaceutical and medical device industry leaders, is pleased to announce the appointment of Dr. Uwe Buecheler, as Non-Executive Director (NED) to its Board of Directors, effective May 19, 2025.Dr. Buecheler brings a wealth of experience and expertise in the biopharmaceutical industry, having held various leadership roles in development operations, strategic planning, and innovation. He has overseen more than 30 biologics launches, including several top global biopharmaceuticals and has held senior roles in regulatory affairs, CMC development, biosafety, quality, CDMO business and operations.Dr. Buecheler led the expansion of Boehringer Ingelheim's Global Operations Network in the US and China and pioneered the first Biologics MAH approval in Shanghai. He also contributed to major expansion projects in aseptic processing, microbial manufacturing, and large-scale mammalian cell culture operations

Pharmaceutical Manufacturer Media
Sep 2nd, 2024
BioPhorum acquires training organisation Brookwood Global

BioPhorum acquires training organisation Brookwood Global.

PharmiWeb.com
Aug 27th, 2024
BioPhorum Acquires Brookwood Global Training

BioPhorum has acquired UK-based training provider Brookwood Global. This acquisition aims to integrate Brookwood's digital training expertise with BioPhorum's biopharmaceutical and life sciences knowledge, creating growth opportunities for both organizations. BioPhorum CEO Deborah Kobewka highlighted that this partnership will help expand BioPhorum's services and develop practical training resources for its members.

INACTIVE